Biotinylated Recombinant Human TNFRSF10D/DcR2/TRAIL-R4/CD264 Protein

Größe

£657.00

SKU:: RP02087B
Zusätzliche Namen:: CD264, DCR2, TRAIL-R4, TRAILR4, TRUNDD,TNFRSF10D,DCR2,TRAIL-R4,TRAILR4,TRUNDD
Molekulargewicht:: 38-50 kDa
Reinheit:: ≥ 95 % as determined by Tris-Bis PAGE;≥ 95 %
Lagerbedingungen:: -20[o]C reconstituted. Avoid freeze/thaw cycles., 2-8[o]C reconstituted., -20[o]C/-70[o]C lyophilized. Avoid freeze/thaw cycles.
Hersteller:: Abclonal
Immunogen:: Ala56-His211
Formulierung:: Biotinylated Recombinant Human TNFRSF10D/DcR2/TRAIL-R4/CD264 Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Ala56-His211) of Human TNFRSF10D/DcR2/TRAIL-R4/CD264 fused with His tag and Avi tag at the C-terminus.
Spezies:: Human
Uniprot:: Q9UBN6
Synonyme:: CD264;DCR2;decoy receptor 2;TNF receptor-related receptor for TRAIL;TNF-related apoptosis-inducing ligand receptor 4;TRAIL receptor 4;TRAIL receptor with a truncated death domain;TRAIL-R4;TRAILR4;TRUNDD;tumor necrosis factor receptor superfamily member 10D;tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
Weitere Details:: TNF-related apoptosis inducing ligand (TRAIL) is a potential antitumor protein known for its ability to selectively eliminate various types of tumor cells without exerting toxic effects in normal cells and tissues. TRAIL-R2/DR5 as well as TRAIL-R3/DcR1 and TRAIL-R4/DcR2 were significantly higher expressed in advanced tumour stages.